Adiponectin: Two studies (107 participants) were pooled for the analysis of serum adiponectin (Electronic Supplementary Fig
The demonstrated importance of protecting the terminals to pharmacokinetic characteristics suggests numerous additional synthetic approaches that may be applicable including the insertion of non-peptide linkages between the first and second amino acids, the replacement of the N~terminal amino acid with a non-a amino acid, and N-terminal acylation
Components of GLOW Protocol BPC-157 BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids and is widely referenced in peptide research literature
Beyond weight loss: a case study and narrative review of the potential role of glucagon-like peptide-1 receptor agonists for the treatment of idiopathic intracranial hypertension Introduction Idiopathic intracranial hypertension (IIH), or pseudotumor cerebri, is a disorder characterized by elevated intracranial pressure (ICP) with no identifiable structural cause, such as a mass lesion or obstructive hydrocephalus
PT-141 is linear, with a free acid C-terminal end, generating conformational flexibility preferring certain receptors (MC4R, MC3R) over others (MC1R)